Tracking down deposits on artery walls

Can nanovectors be used to diagnose and treat atheromas—the fatty deposits on artery walls that can eventually lead to a heart attack or stroke? This question is at the heart of the EU’s NanoAthero project, which was launched in March 2013 and is being coordinated by INSERM. Scientists will test five types of nanovectors including Leti’s Lipidots® (biodegradable oil nanodroplets), already used in imaging and cosmetics.
Diagnosing atheromas is currently more art than science; doctors tend to put patients on cholesterol medication just to be safe.
NanoAthero is a €10-million, five-year project that will include clinical trials on 30 patients. It gives Leti an opportunity to ramp up production of its Lipidots®, while respecting pharmaceutical industry best practices.

Contact: patrick.boisseau@cea.fr

Facebook

Twitter